Arm Holdings plc - American Depositary Shares (ARM)

Myomo (NYSEAMERICAN:MYO) reported record third-quarter revenue of $12.3 million, up 22% from a year earlier, and narrowed its full-year revenue guidance as referrals and higher sales of its powered arm braces helped improve operating performance. The company reached approximately break-even adjuste

CAMP4 Therapeutics (NASDAQ:CAMP) expects initial data from its SYNGAP1 clinical program in the first half of 2028, as the company prepares to begin dosing patients with a treatment designed to increase expression of a gene associated with a rare neurological disorder. Chief Executive Officer Josh M

Phase 3 hepatitis C data met its endpoints and funding now extends into mid-2028.

Management outlined AXPAXLI's regulatory path and late-stage trial updates.

Arm shares sank despite an upbeat outlook for the company's new CPU business.

Both of these stocks saw their shares in free fall following earnings.

Only one of the two deals is new business. Is the stock's drop an opening?

The impending change in the political backdrop isn't apt to actually affect the growing demand for its equipment, either.

All three chip stocks are more than half off their peaks. Only one expects its sales growth to keep speeding up.

For a price as low as 2x revenue, Rocket Lab has created a new space robots business for itself.

Which of these four businesses is still earning more money from your phone?

Investors still don't seem to appreciate Arm's upside potential.

Data center royalties doubled, but memory costs are squeezing smartphone demand.

The long-term visibility of Arm Holdings' recurring revenue isn't quite impressive.

Reality is finally setting in for several chipmakers.

The Nasdaq is falling again after Wednesday's rally. If the past month's swings have worn on you, here's how we're thinking about them.

A day after the midterms hammered AI stocks, the selling deepened and dragged the whole market down with it. Here's what's driving it and whether it's a chance to buy.

Chip stocks continued to fall Thursday in the wake of Tuesday's election results and earnings reports from Arm, Qualcomm and others.

What happened? Shares of latin American e-commerce and fintech company MercadoLibre (NASDAQ:MELI) fell 14% in the morning session after the company reported ...

Promotional pricing lifted test volume sharply, but margins fell and losses widened.

The better foundry stock looks like a clear choice.

ARM (NASDAQ:ARM) reported record second-quarter fiscal 2027 revenue as licensing demand and data center royalties grew, while executives said they had greater confidence in the sales potential of the company’s forthcoming Arm AGI CPU. Revenue rose 27% year over year to $1.44 billion, marking Arm’s

Arm beat analyst estimates for its fiscal second quarter and with its guidance for the current period. But Arm stock fell.

Ciprocopan's China approval and pending FDA path define this pivotal quarter.